RUBY

Rubius Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Rubius Therapeutics Inc RUBY NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -8.62% 1.06 18:33:53
Open Price Low Price High Price Close Price Prev Close
1.18 0.9999 1.18 1.01 1.16
more quote information »

Recent News

Date Time Source Heading
5/18/202211:48IHNWFeaturedEmerging Markets Report: Details, Details
5/18/20229:25IHNWFeaturedAmerican Green, Inc. ™ (OTC:ERBB) Purchases 40,000sq.ft. Cannabis Grow Building for $3,750,000
5/18/20229:11IHNWFeaturedGrove Inc. Programmatic Ad Technology, Interactive Offers, Secures Milestone Patent
5/18/20229:11IHNWFeaturedAgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group (MNG)
5/13/202216:44EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202216:37EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202216:34EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202216:30EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202208:31EDGARCurrent Report Filing (8-k)
5/11/202206:27TRMNH.C. Wainwright Remains a Buy on Rubius Therapeutics (RUBY)
5/10/202212:38TRMNRubius Therapeutics (RUBY) Gets a Hold Rating from SVB..
5/10/202208:46EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/10/202208:31EDGARQuarterly Report (10-q)
5/10/202208:16EDGARCurrent Report Filing (8-k)
5/10/202208:00GLOBERubius Therapeutics Reports First Quarter 2022 Financial..
4/26/202208:00GLOBERubius Therapeutics to Announce First Quarter 2022 Financial..
4/22/202218:08EDGARStatement of Changes in Beneficial Ownership (4)
4/11/202208:40TRMNAnalysts Offer Insights on Healthcare Companies: Nurix..
4/11/202206:27TRMNRubius Therapeutics (RUBY) Gets a Buy Rating from H.C...
4/08/202216:21SEEKRubius Therapeutics falls 45% after updated early-stage data..
4/08/202213:00GLOBERubius Therapeutics Reports Updated Clinical Data at AACR..
4/07/202208:00GLOBERubius Therapeutics to Host Investor Webcast to Discuss..
3/30/202208:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/30/202208:01EDGARProxy Statement (definitive) (def 14a)
3/08/202216:30GLOBERubius Therapeutics to Present Updated Results from..
2/28/202209:00PRNUSAlltrna Appoints Rare Disease Clinical Research Expert, Dr...
2/25/202208:31EDGARAnnual Report (10-k)
2/25/202208:17EDGARCurrent Report Filing (8-k)
2/25/202208:08SEEKRubius Therapeutics GAAP EPS of -$0.61 misses by $0.02
2/25/202208:00GLOBERubius Therapeutics Reports Fourth Quarter and Full Year..
2/15/202210:05PRNUSINVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE..
2/14/202216:15GLOBERubius Therapeutics to Announce Fourth Quarter and Full Year..
2/14/202215:01EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202210:27EDGARAmended Statement of Ownership (sc 13g/a)
2/01/202208:00GLOBERubius Therapeutics to Present at the Virtual Guggenheim..
1/13/202209:25SEEKRubius Therapeutics begins dosing in phase 1/2 trial of..
1/13/202208:00GLOBERubius Therapeutics Announces Dosing of First Patient in..
1/10/202208:00GLOBERubius Therapeutics Recaps 2021 Achievements and Outlines..
1/04/202216:15GLOBERubius Therapeutics to Present at the Virtual 40th Annual..
12/20/202104:09TRMNLeerink Partners Maintains Their Hold Rating on Rubius..
12/16/202109:13SEEKRubius to report additional Phase 1 data for RTX-240 in..
12/16/202108:00GLOBERubius Therapeutics to Highlight the Power of its RED..
12/02/202109:00GLOBERubius Therapeutics Named to the List of Top Places to Work..
12/01/202116:15GLOBERubius Therapeutics to Host Virtual Preclinical Pipeline and..
11/23/202108:00GLOBERubius Therapeutics to Participate in Evercore ISI 4th..
11/12/202107:00GLOBERubius Therapeutics Presents Preclinical Data for RTX-224, a..
11/09/202108:30GLOBERubius Therapeutics to Participate in Jefferies London..
11/08/202116:37SEEKRubius Therapeutics EPS beats by $0.02
11/08/202116:21EDGARCurrent Report Filing (8-k)
11/08/202116:15GLOBERubius Therapeutics Reports Third Quarter 2021 Financial..
10/28/202109:00GLOBERubius Therapeutics to Announce Third Quarter 2021 Financial..
10/13/202110:11PRNUSInvaio Sciences Secures $50 Million Debt Financing to..
10/01/202108:00GLOBERubius Therapeutics Announces Preclinical Data for RTX-224,..


Your Recent History
NASDAQ
RUBY
Rubius The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.